AGM/EGMApr 27, 2026, 07:37 AM
BCAX 2026 Annual Meeting: Elect Directors, Ratify Auditor
AI Summary
Bicara Therapeutics Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 9, 2026. Stockholders of record as of April 15, 2026, will vote on the election of two Class II directors and the ratification of KPMG LLP as the independent registered public accounting firm for fiscal year 2026. The board of directors will also be reduced from ten to nine members, as Nils Lonberg, Ph.D. will not stand for re-election.
Key Highlights
- Annual Meeting of Stockholders to be held virtually on June 9, 2026, at 9:00 a.m. Eastern Time.
- Record date for voting is April 15, 2026.
- Stockholders to elect two Class II directors: Christopher Bowden, M.D. and Carolyn Ng, Ph.D.
- Stockholders to ratify KPMG LLP as independent registered public accounting firm for fiscal year 2026.
- Board of directors size will be reduced from ten to nine members.
- Nils Lonberg, Ph.D. will not stand for re-election as a Class II director.
- 65,600,370 shares of common stock outstanding and entitled to vote as of April 15, 2026.
Price Impact
More from BCAX